David Langlais
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- interferon and immune responses
- Immune cells in cancer
- Molecular Biology top 10%
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- Developmental Biology and Gene Regulation
- Ubiquitin and proteasome pathways
Papers in
- Immunology 28
- interferon and immune responses 10
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 5
-
- Ubiquitin and proteasome pathways 8
- RNA modifications and cancer 4
- Co-authors
- Philippe Gros (18 shared papers)Jacques Drouin (6 shared papers)Catherine Couture (5 shared papers)Luis B. Barreiro (2 shared papers)Aurélio Balsalobre (3 shared papers)Marie Kmita (3 shared papers)Nassima Fodil (6 shared papers)Anastasia Nijnik (14 shared papers)
- Journals
- Frontiers in Immunology (5 papers)Scientific Reports (3 papers)PLoS Genetics (3 papers)Stem Cell Research & Therapy (2 papers)Blood (2 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
David Langlais
53 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 121
- Immunology 527
- Molecular Biology 666
- Cancer Research 128
- Genetics 200
- Oncology 177
Countries citing papers authored by David Langlais
This map shows the geographic impact of David Langlais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Langlais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Langlais more than expected).
Fields of papers citing papers by David Langlais
This network shows the impact of papers produced by David Langlais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Langlais. The network helps show where David Langlais may publish in the future.
Co-authors
The 25 scholars most cited alongside David Langlais, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 164 | |
| 2 | 2012 | 153 | |
| 3 | 2013 | 141 | |
| 4 | 2022 | 66 | |
| 5 | 2011 | 60 | |
| 6 | 2016 | 60 | |
| 7 | 2014 | 53 | |
| 8 | 2015 | 53 | |
| 9 | 2016 | 52 | |
| 10 | 2015 | 48 | |
| 11 | 2013 | 43 | |
| 12 | 2017 | 42 | |
| 13 | 2008 | 42 | |
| 14 | 2014 | 41 | |
| 15 | 2016 | 40 | |
| 16 | 2010 | 36 | |
| 17 | 2015 | 34 | |
| 18 | 2016 | 33 | |
| 19 | 2013 | 31 | |
| 20 | The role of Leishmania GP63 in the modulation of innate inflammatory response to Leishmania major infection | 2021 | 28 |
About David Langlais
David Langlais is a scholar working on Immunology, Molecular Biology, Public Health, Environmental and Occupational Health, Oncology and Epidemiology, having authored 57 papers that have together received 1.6k indexed citations. Recurring topics across this work include interferon and immune responses (10 papers), Immune Cell Function and Interaction (10 papers), Ubiquitin and proteasome pathways (8 papers), Immunotherapy and Immune Responses (6 papers), Immune cells in cancer (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Research on Leishmaniasis Studies (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Immunology (527 citations), Molecular Biology (666 citations), Cancer Research (128 citations), Genetics (200 citations) and Oncology (177 citations). David Langlais has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Philippe Gros, Jacques Drouin, Catherine Couture, Luis B. Barreiro, Aurélio Balsalobre, Marie Kmita, Nassima Fodil, Anastasia Nijnik, Annie Dumouchel and Soizik Berlivet. Their work appears in journals such as Frontiers in Immunology, Scientific Reports, PLoS Genetics, Stem Cell Research & Therapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.